Showing results (241-250 of 429) with videos related to

Sort By:
Pageof 43
International Journal of Molecular Sciences|September 16, 2015
Physiological Dynamics in Demyelinating Diseases: Unraveling Complex Relationships through Computer ModelingJay S Coggan, Stefan Bittner, Klaus M Stiefel, et al.
Brain Imaging and Behavior|November 11, 2015
Changes in brain functional connectivity patterns are driven by an individual lesion in MS: a resting-state fMRI studyAmgad Droby, Kenneth S L Yuen, Muthuraman Muthuraman, et al.
European Journal of Immunology|February 27, 2010
MAPK3 deficiency drives autoimmunity via DC armingIvo Bendix, Caspar F Pfueller, Tina Leuenberger, et al.
Science (New York, N.Y.)|February 26, 2021
Massively parallel ultrafast random bit generation with a chip-scale laserKyungduk Kim, Stefan Bittner, Yongquan Zeng, et al.
Lancet (London, England)|June 20, 2003
TNF-related apoptosis inducing ligand (TRAIL) as a potential response marker for interferon-beta treatment in multiple sclerosisKlaus-Peter Wandinger, Jan D Lünemann, Oliver Wengert, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 8, 2005
Frequency of blood CX3CR1-positive natural killer cells correlates with disease activity in multiple sclerosis patientsCarmen Infante-Duarte, Alexandra Weber, Jörn Krätzschmar, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 6, 2004
Progressive change in primary progressive multiple sclerosis normal-appearing white matter: a serial diffusion magnetic resonance imaging studyKlaus Schmierer, Daniel R Altmann, Nadja Kassim, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 14, 2010
Therapeutic approaches to multiple sclerosis: an update on failed, interrupted, or inconclusive trials of immunomodulatory treatment strategiesJochen C Ulzheimer, Sven G Meuth, Stefan Bittner, et al.
Experimental & Translational Stroke Medicine|December 31, 2013
Ischemia-induced cell depolarization: does the hyperpolarization-activated cation channel HCN2 affect the outcome after stroke in mice?Petra Ehling, Eva Göb, Stefan Bittner, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|August 28, 2010
Therapeutic approaches to multiple sclerosis: an update on failed, interrupted, or inconclusive trials of neuroprotective and alternative treatment strategiesSven G Meuth, Stefan Bittner, Jochen C Ulzheimer, et al.
Pageof 43